Rayoncil

Search documents
Mesoblast (MESO) - 2025 H2 - Earnings Call Transcript
2025-08-28 23:32
Mesoblast (MESO) H2 2025 Earnings Call August 28, 2025 06:30 PM ET Company ParticipantsSilviu Itescu - Founder, CEO & MDAndrew Chaponnel - Interim CFOMarcelo Santoro - Chief Commercial OfficerConference Call ParticipantsEdward Tenthoff - MD & Senior Research AnalystOlivia Brayer - Director & Senior Biotech AnalystElyse Shapiro - Senior Analyst - HealthcareMichael Okunewitch - Senior Research Analyst - BiotechnologyJohn Hester - Senior AnalystOperatorHello, and welcome to the Mesoblast Financial Results for ...